Cita APA (7a ed.)

Hu, C., Yu, M., Ren, Y., Li, K., Maggio, D. M., Mei, C., . . . Tong, H. (2017). PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation. Nature Portfolio.

Cita Chicago Style (17a ed.)

Hu, Chao, et al. PP2A Inhibition from LB100 Therapy Enhances Daunorubicin Cytotoxicity in Secondary Acute Myeloid Leukemia via MiR-181b-1 Upregulation. Nature Portfolio, 2017.

Cita MLA (8a ed.)

Hu, Chao, et al. PP2A Inhibition from LB100 Therapy Enhances Daunorubicin Cytotoxicity in Secondary Acute Myeloid Leukemia via MiR-181b-1 Upregulation. Nature Portfolio, 2017.